Cargando…
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
Kinesin family member 21b (kif21b) is one of the few multiple sclerosis (MS) risk genes with a presumed central nervous system function. Kif21b belongs to the kinesin family, proteins involved in intracellular transport of proteins and organelles. We hypothesised that kif21b is involved in the neuro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207309/ https://www.ncbi.nlm.nih.gov/pubmed/25274010 http://dx.doi.org/10.1186/s40478-014-0144-4 |
_version_ | 1782340947506364416 |
---|---|
author | Kreft, Karim L van Meurs, Marjan Wierenga-Wolf, Annet F Melief, Marie-Jose van Strien, Miriam E Hol, Elly M Oostra, Ben A Laman, Jon D Hintzen, Rogier Q |
author_facet | Kreft, Karim L van Meurs, Marjan Wierenga-Wolf, Annet F Melief, Marie-Jose van Strien, Miriam E Hol, Elly M Oostra, Ben A Laman, Jon D Hintzen, Rogier Q |
author_sort | Kreft, Karim L |
collection | PubMed |
description | Kinesin family member 21b (kif21b) is one of the few multiple sclerosis (MS) risk genes with a presumed central nervous system function. Kif21b belongs to the kinesin family, proteins involved in intracellular transport of proteins and organelles. We hypothesised that kif21b is involved in the neurodegenerative component of MS and Alzheimer's (AD) disease. Post-mortem kinesin expression was assessed in 50 MS, 58 age and gender matched non-demented controls (NDC) and 50 AD. Kif21b expression was five-fold increased in AD compared to MS and NDC aged below 62 years (p = 8*10(-5)), three-fold between 62-72 years (p = 0.005) and not different above 72 years. No significant differences were observed between MS and NDC. In AD, kif21b expression was two-fold increased in Braak stage 6 (scoring for density of neurofibrillary tangles) compared with stage 5 (p = 0.003). In MS patients, kif21b correlated with the extent of grey matter demyelination (Spearman's rho = 0.31, p = 0.03). Abundant kif21b, defined as expression above the median, was associated with a two-fold accelerated development of the Kurtzke Expanded Disability Status Scale (EDSS) 6.0 (median time in low kif21b group 16 years vs. high kif21b 7.5 years, log-rank test p = 0.04) in MS. Given the genetic association of kif21b with MS, the results were stratified according to rs12122721[A] single nucleotide polymorphism (SNP). No association was found between kif21b expression or the time to EDSS 6 in kif21b risk SNP carriers compared to non-risk carriers. Kif21b was expressed in astrocytes in addition to neurons. Upon astrocyte activation, kif21b increased nine-fold. Abundant kif21b expression is associated with severe MS and AD pathology and with accelerated neurodegeneration independent of the kif21b risk SNP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-014-0144-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4207309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42073092014-10-28 Abundant kif21b is associated with accelerated progression in neurodegenerative diseases Kreft, Karim L van Meurs, Marjan Wierenga-Wolf, Annet F Melief, Marie-Jose van Strien, Miriam E Hol, Elly M Oostra, Ben A Laman, Jon D Hintzen, Rogier Q Acta Neuropathol Commun Research Kinesin family member 21b (kif21b) is one of the few multiple sclerosis (MS) risk genes with a presumed central nervous system function. Kif21b belongs to the kinesin family, proteins involved in intracellular transport of proteins and organelles. We hypothesised that kif21b is involved in the neurodegenerative component of MS and Alzheimer's (AD) disease. Post-mortem kinesin expression was assessed in 50 MS, 58 age and gender matched non-demented controls (NDC) and 50 AD. Kif21b expression was five-fold increased in AD compared to MS and NDC aged below 62 years (p = 8*10(-5)), three-fold between 62-72 years (p = 0.005) and not different above 72 years. No significant differences were observed between MS and NDC. In AD, kif21b expression was two-fold increased in Braak stage 6 (scoring for density of neurofibrillary tangles) compared with stage 5 (p = 0.003). In MS patients, kif21b correlated with the extent of grey matter demyelination (Spearman's rho = 0.31, p = 0.03). Abundant kif21b, defined as expression above the median, was associated with a two-fold accelerated development of the Kurtzke Expanded Disability Status Scale (EDSS) 6.0 (median time in low kif21b group 16 years vs. high kif21b 7.5 years, log-rank test p = 0.04) in MS. Given the genetic association of kif21b with MS, the results were stratified according to rs12122721[A] single nucleotide polymorphism (SNP). No association was found between kif21b expression or the time to EDSS 6 in kif21b risk SNP carriers compared to non-risk carriers. Kif21b was expressed in astrocytes in addition to neurons. Upon astrocyte activation, kif21b increased nine-fold. Abundant kif21b expression is associated with severe MS and AD pathology and with accelerated neurodegeneration independent of the kif21b risk SNP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-014-0144-4) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-03 /pmc/articles/PMC4207309/ /pubmed/25274010 http://dx.doi.org/10.1186/s40478-014-0144-4 Text en © Kreft et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Kreft, Karim L van Meurs, Marjan Wierenga-Wolf, Annet F Melief, Marie-Jose van Strien, Miriam E Hol, Elly M Oostra, Ben A Laman, Jon D Hintzen, Rogier Q Abundant kif21b is associated with accelerated progression in neurodegenerative diseases |
title | Abundant kif21b is associated with accelerated progression in neurodegenerative diseases |
title_full | Abundant kif21b is associated with accelerated progression in neurodegenerative diseases |
title_fullStr | Abundant kif21b is associated with accelerated progression in neurodegenerative diseases |
title_full_unstemmed | Abundant kif21b is associated with accelerated progression in neurodegenerative diseases |
title_short | Abundant kif21b is associated with accelerated progression in neurodegenerative diseases |
title_sort | abundant kif21b is associated with accelerated progression in neurodegenerative diseases |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207309/ https://www.ncbi.nlm.nih.gov/pubmed/25274010 http://dx.doi.org/10.1186/s40478-014-0144-4 |
work_keys_str_mv | AT kreftkariml abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases AT vanmeursmarjan abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases AT wierengawolfannetf abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases AT meliefmariejose abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases AT vanstrienmiriame abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases AT holellym abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases AT oostrabena abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases AT lamanjond abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases AT hintzenrogierq abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases |